US Stocks
/
Vivos Therapeutics, Inc. Share Price

Vivos Therapeutics, Inc. Share Price

NASDAQ: VVOS | Micro Cap
$0.32
-$0.00 (-0.09%) Last updated on 08 Aug, 2026 | 00:58 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Vivos Therapeutics, Inc. Stock Performance

Open
$0.31
Prev. Close
$0.32
Circuit Range
N/A
Day Range
$0.31 - $0.35
Year Range
$0.31 - $5.11
Volume
8,094
Average Traded
$0.33

Vivos Therapeutics, Inc. Share Price Today

As of 10 August 2026, Vivos Therapeutics, Inc.'s share price is $0.32. The stock opened at $0.31, compared to its previous close of $0.32. During today's trading session, Vivos Therapeutics, Inc.'s share price traded between $0.31 and $0.35, with an average price of $0.33. Over the past 52 weeks, the stock has recorded a high of $5.11 and a low of $0.31. In terms of performance, Vivos Therapeutics, Inc.'s share price has declined by 76.99% over the last six months and is down 92.51% on a year-on-year basis.

Vivos Therapeutics, Inc. Share Price Chart

$0.31$0.35
L
Show Current Price
H

Vivos Therapeutics, Inc. Stock Fundamentals & Key Indicators

Market Cap
$3.33M
PE Ratio (TTM)
-0.16
Dividend Yield
N/A
EPS (TTM)
$-2.07
Revenue (TTM)
$17.44M
Return On Equity (TTM)
1424.83%
Profit Margin
-121.71%
Debt to Equity
-12.13
Quarterly Earnings Growth YoY
-106.42%

Vivos Therapeutics, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsMar 2024Jun 2024Sep 2024Mar 2025Jun 2025Sep 2025
RevenueN/A$4.05M$3.86M$3.02M$3.82M$6.78M
Net Profit-$3.76M-$1.93M-$2.62M-$3.86M-$5.01M-$5.40M
Net Profit MarginN/A-47.61%-67.77%-128.12%-131.23%-79.61%
Income ChangeN/A48.71%-35.54%-47.71%-29.74%-7.72%

Vivos Therapeutics, Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$16.02M$13.80M$15.03M$17.44M
Net Profit-$23.84M-$13.58M-$11.14M-$21.17M
Net Profit Margin-148.81%-98.42%-74.09%-121.37%
Income ChangeN/A43.04%18.02%-90.10%

About Vivos Therapeutics, Inc.

Vivos Therapeutics, Inc. operates as a medical technology company that develops and commercializes treatment modalities for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers The Vivos Method, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dentofacial abnormalities, OSA, and snoring. The company also offers VivoScore Program, a screening and home sleep test in adults and children. It markets and sells its appliances, and related treatments and services to licensed professionals, primarily general dentists in the United States and Canada. Vivos Therapeutics, Inc. was founded in 2016 and is based in Littleton, Colorado.

Vivos Therapeutics, Inc. Historical Returns

MonthOpenCloseChange %
Aug 2026
$0.42
$0.32
-20.98%
Jul 2026
$0.50
$0.41
-8.28%
Jun 2026
$0.66
$0.45
-33.28%
May 2026
$0.81
$0.67
-17.28%
Apr 2026
$1.27
$0.81
-28.95%
Mar 2026
$1.32
$1.14
-19.15%
Feb 2026
$1.65
$1.41
-12.96%
Jan 2026
$2.28
$1.62
-19.60%
Dec 2025
$2.22
$2.02
-11.62%
Nov 2025
$2.45
$2.28
-12.64%
Oct 2025
$3.12
$2.61
-15.81%
Sep 2025
$4.35
$3.10
-28.41%

VVOS Share Price FAQs

What is Vivos Therapeutics, Inc. share price today?

chevron-up
Vivos Therapeutics, Inc. share price today is $0.32 as on August 8, 2026 at 12:58 am IST.

What is the 52 week high and 52 week low of Vivos Therapeutics, Inc. stock?

chevron-up
The 52 week high of Vivos Therapeutics, Inc. stock is $5.11, while the 52 week low is $0.31 as of 8 Aug '26.

What is VVOS's market capitalisation today?

chevron-up
VVOS market capitalisation is $3.33M as of August 10, 2026, at 10:39 am IST.

What is VVOS's net income for the last quarter?

chevron-up
VVOS's net income for the last quarter is -0.01B USD.

What is the 5 year returns of VVOS?

chevron-up
The 5 year returns of VVOS is -99.75% as on 8 Aug '26.

What is the high & low stock price of VVOS today?

chevron-up
VVOS stock price hit a high of $0.35 and low of $0.31 as of 8 Aug '26.

Can I buy VVOS shares in India?

chevron-up
Yes. You can buy VVOS in India by opening an international trading account.